-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Ve0OLsKOk9oR1CxYFvx9XnPhtIm7+/emMVCvEgiNR0ze4ABtidRUgQBH0M+mSrHk
 bJSYvMnwXPgKAgSjnS/YoA==

<SEC-DOCUMENT>0001181431-10-038100.txt : 20100721
<SEC-HEADER>0001181431-10-038100.hdr.sgml : 20100721
<ACCEPTANCE-DATETIME>20100721132702
ACCESSION NUMBER:		0001181431-10-038100
CONFORMED SUBMISSION TYPE:	4/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20100608
FILED AS OF DATE:		20100721
DATE AS OF CHANGE:		20100721

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			JAEGER STEPHEN O
		CENTRAL INDEX KEY:			0001243960

	FILING VALUES:
		FORM TYPE:		4/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-15313
		FILM NUMBER:		10962056

	MAIL ADDRESS:	
		STREET 1:		11 TOPSTONE ROAD
		CITY:			REDDING
		STATE:			CT
		ZIP:			06896

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SAVIENT PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000722104
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				133033811
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		ONE TOWER CENTER
		CITY:			EAST BRUNSWICK
		STATE:			NJ
		ZIP:			08816
		BUSINESS PHONE:		7324189300

	MAIL ADDRESS:	
		STREET 1:		ONE TOWER CENTER
		CITY:			EAST BRUNSWICK
		STATE:			NJ
		ZIP:			08816

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIO TECHNOLOGY GENERAL CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>4/A
<SEQUENCE>1
<FILENAME>rrd281594.xml
<DESCRIPTION>FORM 4/A FOR S JAEGER
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0303</schemaVersion>

    <documentType>4/A</documentType>

    <periodOfReport>2010-06-08</periodOfReport>

    <dateOfOriginalSubmission>2010-06-10</dateOfOriginalSubmission>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0000722104</issuerCik>
        <issuerName>SAVIENT PHARMACEUTICALS INC</issuerName>
        <issuerTradingSymbol>SVNT</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001243960</rptOwnerCik>
            <rptOwnerName>JAEGER STEPHEN O</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>SAVIENT PHARMACEUTICALS, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>ONE TOWER CENTER, 14TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>EAST BRUNSWICK</rptOwnerCity>
            <rptOwnerState>NJ</rptOwnerState>
            <rptOwnerZipCode>08816</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock, $.01 par value per share</value>
            </securityTitle>
            <transactionDate>
                <value>2010-06-08</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
                <footnoteId id="F1"/>
                <footnoteId id="F2"/>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>7029</value>
                </transactionShares>
                <transactionPricePerShare>
                    <footnoteId id="F3"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>56063</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">The right to receive these shares is pursuant to a restricted stock unit grant, 100% of which shall vest 30 days from the first anniversary of the Company's 2010 Annual Meeting of Stockholders.  Mr. Jaeger has elected to defer receipt of such shares upon vesting until the earliest of his death, disability or retirement from the Board of Directors of the Company and a change of control of the Company.</footnote>
        <footnote id="F2">Due to administrative error, Mr. Jaeger was reported in a filing on June 10, 2010 to have acquired 7,029 shares of restricted stock on June 8, 2010.</footnote>
        <footnote id="F3">Mr. Jaeger received these restricted stock units as a grant forming part of his annual compensation as a director and Chairman of the Board of the company and for no consideration..  The restricted stock units had an aggregate fair market value of $79,990.32 based on the $11.38 per share closing price of the Company's common stock as quoted by the Nasdaq Global Market on the date of grant.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Philip K. Yachmetz as Attorney-In-Fact for Stephen O. Jaeger</signatureName>
        <signatureDate>2010-07-21</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----